{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:53:03Z","timestamp":1790650383020,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/ja.2017.108","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T06:20:40Z","timestamp":1505888440000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance"],"prefix":"10.1038","volume":"71","author":[{"given":"Heer H","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy G","family":"Prater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Shamoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"key":"BFja2017108_CR1","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf. Accessed on 3 August 2017."},{"key":"BFja2017108_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1\u201312 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2017108_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197, 1079\u20131081 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFja2017108_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1086\/432121","volume":"41","author":"LS Munoz-price","year":"2005","unstructured":"Munoz-price, L. S., Lolans, K. & Quinn, J. P. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin. Infect. Dis. 41, 565\u2013566 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFja2017108_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrg3564","volume":"14","author":"JE Barrick","year":"2013","unstructured":"Barrick, J. E. & Lenski, R. E. Genome dynamics during experimental evolution. Nat. Rev. Genet. 14, 827\u2013839 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"BFja2017108_CR6","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1126\/science.aag0822","volume":"353","author":"M Baym","year":"2016","unstructured":"Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147\u20131151 (2016).","journal-title":"Science"},{"key":"BFja2017108_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ng.1034","volume":"44","author":"E Toprak","year":"2012","unstructured":"Toprak, E. et al. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat. Genet. 44, 101\u2013105 (2012).","journal-title":"Nat. Genet."},{"key":"BFja2017108_CR8","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1126\/science.1208747","volume":"333","author":"Q Zhang","year":"2011","unstructured":"Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764\u20131767 (2011).","journal-title":"Science"},{"key":"BFja2017108_CR9","doi-asserted-by":"publisher","first-page":"e0140489","DOI":"10.1371\/journal.pone.0140489","volume":"10","author":"TG Hammerstrom","year":"2015","unstructured":"Hammerstrom, T. G., Beabout, K., Clements, T. P., Saxer, G. & Shamoo, Y. Acinetobacter baumannii repeatedly evolves a hypermutator phenotype in response to tigecycline that effectively surveys evolutionary trajectories to resistance. PLoS ONE 10, e0140489 (2015).","journal-title":"PLoS ONE"},{"key":"BFja2017108_CR10","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/molbev\/msv133","volume":"32","author":"K Beabout","year":"2015","unstructured":"Beabout, K. et al. Rampant parasexuality evolves in a hospital pathogen during antibiotic selection. Mol. Biol. Evol. 32, 2585\u20132597 (2015).","journal-title":"Mol. Biol. Evol."},{"key":"BFja2017108_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMoa1011138","volume":"365","author":"CA Arias","year":"2011","unstructured":"Arias, C. A. et al. Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl. J. Med. 365, 892\u2013900 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFja2017108_CR12","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1128\/AAC.01473-13","volume":"57","author":"C Miller","year":"2013","unstructured":"Miller, C. et al. Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance. Antimicrob. Agents Chemother. 57, 5373\u20135383 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017108_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ijantimicag.2016.01.005","volume":"47","author":"X Li","year":"2016","unstructured":"Li, X. et al. Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo. Int. J. Antimicrob. Agents 47, 324\u2013327 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja2017108_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ijantimicag.2015.07.009","volume":"46","author":"M Niebel","year":"2015","unstructured":"Niebel, M. et al. Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium. Int. J. Antimicrob. Agents 46, 572\u2013575 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"BFja2017108_CR15","doi-asserted-by":"publisher","first-page":"e01603","DOI":"10.1128\/mBio.01603-15","volume":"6","author":"JL Murray","year":"2015","unstructured":"Murray, J. L., Kwon, T., Marcotte, E. M. & Whiteley, M. Intrinsic antimicrobial resistance determinants in the superbug Pseudomonas aeruginosa. mBio 6, e01603\u2013e01615 (2015).","journal-title":"mBio"},{"key":"BFja2017108_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","volume":"288","author":"A Oliver","year":"2000","unstructured":"Oliver, A., Cant\u00f3n, R., Campo, P., Baquero, F. & Bl\u00e1zquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251\u20131253 (2000).","journal-title":"Science"},{"key":"BFja2017108_CR17","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1128\/JCM.00357-08","volume":"46","author":"DJ Waine","year":"2008","unstructured":"Waine, D. J., Honeybourne, D., Smith, E. G., Whitehouse, J. L. & Dowson, C. G. Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa. J. Clin. Microbiol. 46, 3491\u20133493 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"BFja2017108_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1128\/AAC.05829-11","volume":"56","author":"SM Moskowitz","year":"2012","unstructured":"Moskowitz, S. M. et al. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Antimicrob. Agents Chemother. 56, 1019\u20131030 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017108_CR19","doi-asserted-by":"publisher","first-page":"25543","DOI":"10.1038\/srep25543","volume":"6","author":"J-Y Lee","year":"2016","unstructured":"Lee, J.-Y., Park, Y. K., Chung, E. S., Na, I. Y. & Ko, K. S. Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa. Sci. Rep. 6, 25543 (2016).","journal-title":"Sci. Rep."},{"key":"BFja2017108_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diagmicrobio.2013.11.027","volume":"78","author":"JY Lee","year":"2014","unstructured":"Lee, J. Y. & Ko, K. S. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn. Microbiol. Infect. Dis. 78, 271\u2013276 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"BFja2017108_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1365-2958.2003.03673.x","volume":"50","author":"JB McPhee","year":"2003","unstructured":"McPhee, J. B., Lewenza, S. & Hancock, R. E. W. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205\u2013217 (2003).","journal-title":"Mol. Microbiol."},{"key":"BFja2017108_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","volume":"5","author":"AO Olaitan","year":"2014","unstructured":"Olaitan, A. O., Morand, S. & Rolain, J. M. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5, 643 (2014).","journal-title":"Front. Microbiol."},{"key":"BFja2017108_CR23","first-page":"679109","volume":"2015","author":"Z Yu","year":"2015","unstructured":"Yu, Z., Qin, W., Lin, J., Fang, S. & Qiu, J. Antibacterial mechanisms of polymyxin and bacterial resistance. Biomed Res. Int. 2015, 679109 (2015).","journal-title":"Biomed Res. Int."},{"key":"BFja2017108_CR24","doi-asserted-by":"publisher","first-page":"20150292","DOI":"10.1098\/rstb.2015.0292","volume":"371","author":"H Joo","year":"2016","unstructured":"Joo, H., Fu, C. & Otto, M. Bacterial strategies of resistance to antimicrobial peptides. Phil. Trans. R. Soc. B 371, 20150292 (2016).","journal-title":"Phil. Trans. R. Soc. B"},{"key":"BFja2017108_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","volume":"1151","author":"DE Deatherage","year":"2014","unstructured":"Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165\u2013188 (2014).","journal-title":"Methods Mol. Biol."},{"key":"BFja2017108_CR26","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1128\/AAC.00893-09","volume":"53","author":"K Barrow","year":"2009","unstructured":"Barrow, K. & Kwon, D. H. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 5150\u20135154 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFja2017108_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1574-6968.2009.01720.x","volume":"298","author":"N Abraham","year":"2009","unstructured":"Abraham, N. & Kwon, D. H. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 298, 249\u2013254 (2009).","journal-title":"FEMS Microbiol. Lett."},{"key":"BFja2017108_CR28","doi-asserted-by":"publisher","first-page":"13002","DOI":"10.1038\/ncomms13002","volume":"7","author":"N Jochumsen","year":"2016","unstructured":"Jochumsen, N. et al. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions. Nat. Commun. 7, 13002 (2016).","journal-title":"Nat. Commun."},{"key":"BFja2017108_CR29","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1128\/JB.00048-16","volume":"198","author":"KM Flynn","year":"2016","unstructured":"Flynn, K. M., Dowell, G., Johnson, T. M., Koestler, B. J. & Waters, C. M. Evolution of ecological diversity in biofilms of Pseudomonas aeruginosa by altered cyclic diguanylate signaling. J. Bacteriol. 198, 2608\u20132618 (2016).","journal-title":"J. Bacteriol."},{"key":"BFja2017108_CR30","volume-title":"Tools in Artificial Intelligence","author":"Pavlina Fragkou","year":"2008","unstructured":"Mcdaniel, C. T., Panmanee, W. & Hassett, D. J. in Cystic Fibrosis in the Light of New Research (ed. Wat, D.) doi: 10.5772\/60897 (InTech, 2015)."},{"key":"BFja2017108_CR31","doi-asserted-by":"publisher","first-page":"13680","DOI":"10.1073\/pnas.1205357109","volume":"109","author":"MR Weigand","year":"2012","unstructured":"Weigand, M. R. & Sundin, G. W. General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra. Proc. Natl Acad. Sci. USA 109, 13680\u201313685 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017108_CR32","doi-asserted-by":"publisher","first-page":"21408","DOI":"10.1073\/pnas.1209335110","volume":"109","author":"K Walkiewicz","year":"2012","unstructured":"Walkiewicz, K. et al. Small changes in enzyme function can lead to surprisingly large fitness effects during adaptive evolution of antibiotic resistance. Proc. Natl Acad. Sci. USA 109, 21408\u201321413 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFja2017108_CR33","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1093\/nar\/gkv321","volume":"43","author":"M Davlieva","year":"2015","unstructured":"Davlieva, M. et al. A variable DNA recognition site organization establishes the LiaR-mediated cell envelope stress response of enterococci to daptomycin. Nucleic Acids Res. 43, 4758\u20134773 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFja2017108_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mib.2016.07.002","volume":"33","author":"TT Tran","year":"2016","unstructured":"Tran, T. T., Miller, W. R., Shamoo, Y. & Arias, C. A. Targeting cell membrane adaptation as a novel antimicrobial strategy. Curr. Opin. Microbiol. 33, 91\u201396 (2016).","journal-title":"Curr. Opin. Microbiol."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ja2017108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ja2017108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ja.2017.108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/ja2017108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T01:11:30Z","timestamp":1672535490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja2017108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFja2017108"],"URL":"https:\/\/doi.org\/10.1038\/ja.2017.108","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]},"assertion":[{"value":"30 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}